Vera Therapeutics Inc (VERA)
49.00
-0.43
(-0.87%)
USD |
NASDAQ |
Nov 14, 16:00
49.99
+0.99
(+2.02%)
After-Hours: 07:22
Vera Therapeutics Total Liabilities (Quarterly): 79.50M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 79.50M |
| June 30, 2024 | 69.42M |
| March 31, 2024 | 65.81M |
| December 31, 2023 | 73.86M |
| September 30, 2023 | 51.91M |
| June 30, 2023 | 54.66M |
| March 31, 2023 | 51.90M |
| December 31, 2022 | 54.53M |
| Date | Value |
|---|---|
| September 30, 2022 | 25.65M |
| June 30, 2022 | 27.28M |
| March 31, 2022 | 30.55M |
| December 31, 2021 | 14.16M |
| September 30, 2021 | 5.69M |
| June 30, 2021 | 5.492M |
| March 31, 2021 | 145.14M |
| December 31, 2020 | 143.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.492M
Minimum
Jun 2021
145.14M
Maximum
Mar 2021
56.22M
Average
53.22M
Median
Total Liabilities (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp | 132.92M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.56M |
| Shareholders Equity (Quarterly) | 289.06M |